Hemagen Diagnostics, Inc. (HMGN)

0.0016 0.00 (0.00%) USD  |  OTCM  |  Apr 17, 16:00
More

Hemagen Diagnostics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for HMGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Entia Biosciences, Inc. --
Trevena, Inc. --
Cantabio Pharmaceuticals, Inc. --
Affymax, Inc. --
Scopus Biopharma, Inc. --